Marshall Edwards Appoints CEO as a New Director
May 06, 2010 08:00 ET
|
Marshall Edwards, Inc.
SYDNEY, AUSTRALIA and SAN DIEGO, CA--(Marketwire - May 6, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHL), an oncology company focused on the clinical development of novel anti-cancer...
Nine Educational Models Studied by Over 160 Veterinary Medical Education Stakeholders at Second NAVMEC National Meeting
May 03, 2010 09:00 ET
|
NAVMEC
KANSAS CITY, MO--(Marketwire - May 3, 2010) - A diverse representation of veterinary organizations and individuals ever assembled completed three days of meetings Saturday to examine current...
Marshall Edwards, Inc. Announces Grants Under Nasdaq Rule 5635
April 29, 2010 08:00 ET
|
Marshall Edwards, Inc.
SYDNEY, AUSTRALIA and SAN DIEGO, CA--(Marketwire - April 29, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHLD), a specialist oncology company focusing on the clinical development of novel anti-cancer...
Marshall Edwards Appoints New President and CEO
April 26, 2010 08:00 ET
|
Marshall Edwards, Inc.
SYDNEY, AUSTRALIA and SAN DIEGO, CA--(Marketwire - April 26, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHLD), an oncology company focused on the clinical development of novel anti-cancer therapeutics,...
Marshall Edwards, Inc. Receives Notice of Compliance With Nasdaq Continued Listing Requirements
April 20, 2010 09:00 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - April 20, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics, today...
Novogen Announces New Executive Service Agreements
March 31, 2010 08:00 ET
|
Novogen Limited
SYDNEY, AUSTRALIA--(Marketwire - March 31, 2010) - Novogen Limited (ASX: NRT) (NASDAQ: NVGN) advises that it has entered into new executive service agreements with its seven most senior executives.
...
Marshall Edwards, Inc. Announces Stockholder Approval and Implementation of 1:10 Reverse Stock Split
March 31, 2010 08:00 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - March 31, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHL) (NASDAQ: MSHLD), a specialist oncology company focusing on the clinical development of novel anti-cancer...
HemoBioTech and Its Innovative Blood Substitute HemoTech Could Benefit From House Resolution to Support Small Biotechnology Companies
March 25, 2010 08:00 ET
|
HemoBioTech
DALLAS, TX--(Marketwire - March 25, 2010) - Congressman Danny K. Davis (Il-7th) recently submitted House Resolution 1179, legislation that puts Congress on record in supporting biotechnology...
Marshall Edwards, Inc. Receives Nasdaq Staff Determination
March 19, 2010 08:00 ET
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - March 19, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics,...
New Path to Therapeutic HIV Vaccine Discovered by Studying Immunologic Profile of Rare HIV Controllers
March 17, 2010 11:30 ET
|
Bionor Immuno
OSLO, NORWAY--(Marketwire - March 17, 2010) - Based on encouraging results from pre-clinical research, Bionor Immuno AS today announced intentions to take the therapeutic and potentially...